News

So I didn’t have a Netflix rom-com becoming one of my favorite films of the year on my 2025 bingo card, but here we are. While it did come out in February, I finally had the chance to check it ...
Recent Highlights Alzheimer's Disease Program (PMN310) ProMIS' lead candidate, PMN310, is a humanized IgG1 antibody directed toward toxic amyloid-beta (Ab) oligomers (AßO) that are believed to be ...
Rapid Enrollment and Dosing of First Patients in PRECISE-AD Trial Underscores the Unmet Need for Better Treatment Options for Alzheimer’s Disease PRECISE-AD Six Month Interim Results Expected in ...
Recent Highlights Alzheimer’s Disease Program (PMN310) ProMIS’ lead candidate, PMN310, is a humanized IgG1 antibody directed toward toxic amyloid-beta (Ab) oligomers (AβO) that are believed ...
"2024 was a transformational year for ProMIS Neurosciences as we reached a major milestone with the initiation of our 100-patient Phase 1b clinical trial for PMN310, our lead antibody candidate for AD ...
Brandon Moreno told reporters he wasn't thinking about his winless streak in Mexico, but his cathartic post-fight speech suggests it felt good laying the story to rest. On Saturday, Moreno sent ...
While Kohli has demonstrated significant improvement against spin in recent times, particularly through his increased use of sweeps and slog sweeps, he cannot shoulder the responsibility alone.
2024 and highlighted recent developments. Advancement of IkT-001 as a therapy in Pulmonary Arterial Hypertension: The Company received its Study May Proceed letter for the Phase 2b trial in ...
PALO ALTO, Calif., March 27, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the fourth quarter and full year ended ...